Table 3.
Baseline characteristics of HCM patients with APH.
| APH | |||
|---|---|---|---|
| With HTN (n = 15) | Without HTN (n = 13) | P-value | |
| Demographics | |||
| Age at HCM diagnosis | 54 ± 14.1 | 52 ± 15.6 | 0.756 |
| Medical history and cardiovascular risk factors | |||
| Hyperlipidaemia | 4 (27%) | 4 (31%) | >0.05 |
| Current smoking | 1 (7%) | 4 (31%) | >0.05 |
| CAD | 4 (27%) | 6 (46%) | >0.05 |
| TIA | 3 (20%) | 0 (0%) | >0.05 |
| Chronic renal failure | 0 (0%) | 0 (0%) | >0.05 |
| History of VT | 2 (13%) | 1 (8%) | >0.05 |
| Clinical features | |||
| Angina pectoris | 6 (40%) | 4 (31%) | >0.05 |
| Syncope | 1 (7%) | 0 (0%) | >0.05 |
| Atrial fibrillation | 6 (40%) | 2 (15%) | >0.05 |
| Family history HCM | 1 (7%) | 2 (15%) | >0.05 |
| sudden cardiac death | 0 (0%) | 1 (8%) | >0.05 |
Categorical parameters are presented as n(%). Continuous variables are expressed as mean and standard deviation. HCM, hypertrophic cardiomyopathy; CAD, coronary artery disease; TIA, transient ischaemic attack; VT, ventricular tachycardia.